RSV Prevention, Part IV: Immunocompromised Populations

  • This page as PDF

Summary

Tune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.

Panelists

Moderator
Sarah Moselle , Associate Principal, Policy

Sarah Moselle supports clients with strategy development and implementation across a range of health policy and market access issues in US and international contexts.

Speaker
Haley Payne , Consultant I, Policy

Haley Payne provides subject matter expertise in vaccines, preventive services, pandemic preparedness and response, and healthcare quality to support clients' above-brand and brand-level policy objectives.

Speaker
Elif Alyanak , Associate Principal, Policy

Elif Alyanak supports clients with evidence-based research and analysis that spans a variety of healthcare sectors and stakeholders.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Vaccines and Public Health
Please enter your email address to be notified when new Vaccines and Public Health insights are published.

Back To Top